Insilico Medicine announces validation of the GAN-RL systems for de novo molecular design
Credit: Insilico Medicine 12th of July, 2018, Rockville, MD -- Today Insilico Medicine, a company specializing in artificial intelligence for biomarker and drug discovery and...






